Script section containing code for Liveperson Chat Solution

Hoover's - A D&B Company - We Make It Easier
Buy Reports For This Company

Chugai Pharmaceutical Co., Ltd.
Tokyo Japan
 

btn-overview-2btn-people-1btn-competition-1btn-financials-1

Company Description

Chugai Pharmaceutical develops therapies for bone metabolism and blood disorders, cancer, infectious diseases, immune system disorders, and cardiovascular, kidney, and brain diseases. Products include Neutrogin, which treats white blood cell loss related to chemotherapy; Epogin, which treats red blood cell loss caused by chronic kidney failure; Sigmart, an antianginal agent; and Alfarol for osteoporosis. Chugai Pharmaceuticals has foreign operations in Asia, Europe, and North America through subsidiaries and branch locations. Swiss drugs group Roche owns about 60% of Chugai Pharmaceutical.

1-1 Nihonbashi-Muromachi 2-Chome, Chuo-KuPhone: +81-3-3281-6611http://www.chugai-pharm.co.jp
Tokyo 103-8324Fax: +81-3-3281-2828Map Map This Company
Japan

Try a Full Premium Subscription

Access over 85 million companies
Call (866) 443-3939 or

btn-free-trial

Prepare for your Sales call

Try a Small Business Subscription
Starting $89 per month

btn-subscribe-now

Chugai Pharmaceutical Co., Ltd. Rankings

Nikkei 225

Executives

39 executives listed for Chugai Pharmaceutical Co., Ltd.'s Tokyo, Japan location.
President, CEO, COO, and DirectorOsamu NagayamaE-mail
DirectorAbraham CohenE-mail
DirectorErichHunzikerE-mail

More Chugai Pharmaceutical Co., Ltd. Executives

Financials

Company TypePublicHeadquarters
Fiscal Year-EndDecember
2011 Employees6,779
More Chugai Pharmaceutical Co., Ltd. Financials
D&B logoDNBi

Leverage D&B's credit assessment tools to positively impact
your business. Get the scoop on Chugai Pharmaceutical Co., Ltd. now.

  • Reduce risk.
  • Drive greater profitability.
  • Increase cash flow.
Get a Credit Report Now

Sponsored Links